Synthesis, biological evaluation, and molecular docking study of novel 1,2,4-substituted triazoles as inhibitors of alzheimer’s disease-Reference-Cited by-同舟云学术

Synthesis, biological evaluation, and molecular docking study of novel 1,2,4-substituted triazoles as inhibitors of alzheimer’s disease

Published:2022-08-17 Issue:11 Volume:19 Page:4491-4502
ISSN:1735-207X
Container-title:Journal of the Iranian Chemical Society
language:en
Short-container-title:J IRAN CHEM SOC

Author:

Ali Saima,Siddiqui Sabahat Zahra,Khan Khalid Mohammed,Abbasi Muhammad Athar,Aziz-ur-Rehman ,Saad Syed Muhammad,Shah Syed Adnan Ali,Zaib Saleem Rahman Shah,Ashraf Muhammad

Publisher

Springer Science and Business Media LLC

Subject

General Chemistry

Link

https://link.springer.com/content/pdf/10.1007/s13738-022-02617-5.pdf

Reference42 articles.

1. Y. Madav, S. Wairkar, B. Prabhakar, Recent therapeutic strategies targeting β-amyloid and tauopathies in Alzheimer’s disease. Brain Res. Bull. 146, 171 (2019)

2. S.H. Tan, V. Karri, N.W.R. Tay, K.H. Chang, H.Y. Ah, P.Q. Ng, H.S. Ho, H.W. Keh, M. Candasamy, Emerging pathways to neurodegeneration: dissecting the critical molecular mechanisms in Alzheimer’s disease. Parkinson’s Disease. Biomed. Pharmacother. 111, 765 (2019)

3. C. Huang, H. Chu, Y. Ma, Z. Zhou, C. Dai, X. Huang, L. Fang, Q. Ao, D. Huang, The neuroprotective effect of deep brain stimulation at nucleus basalis of Meynert in transgenic mice with Alzheimer’s disease. Brain Stimul. 12, 161 (2019)

4. S. Burmaoglu, A.O. Yilmaz, M.F. Polat, R. Kaya, I. Gulcin, O. Algul, Synthesis and biological evaluation of novel tris-chalcones as potent carbonic anhydrase, acetylcholinesterase, butyrylcholinesterase, and α-glycosidase inhibitors. Bioorg. Chem. 85, 191 (2019)

5. M.M. Ibrahim, M.T. Gabr, Multitarget therapeutic strategies for Alzheimer’s disease. Neural. Regen. Res. 14, 437 (2019)

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis of triazole-based scaffolds, N-(substitutedphenyl)-2-(5-(4-methoxyphenyl)-4-phenyl-4H-1,2,4-triazol-3-ylthiol)acetamides: As potential anti-cholinesterase agents for neurodegenerative diseases;Journal of Molecular Structure;2023-10

2. Innovative cholinergic scaffolds, synthesis, and characterization of substituted 1,2,4-triazole-3-ylthio-N-acetamides and their in silico studies: supplement against neurodegenerative disease;Journal of the Iranian Chemical Society;2023-01-27